what is a microdose tirzepatide 3- Month Micro-dosing Microdose Tirzepatide | Peptide Therapy

Taking GLP-1s may be one of those decisions that people need to discuss and make with their doctor, knowing that taking the drug requires a long-term commitment, and it may not be the best fit for people who struggle with taking medication daily or weekly. Adherence with GLP-1RAs remains a challenge

Trends & Treatment Insights for 2025 Real-world data show rapid adoption in type 2 diabetes care: between early 2022 and mid-2024, roughly 1 in 5 type 2 diabetes patients were on GLP-1 therapy

Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy

When can hypoglycemia happen

Best For: Consistent NAD+ levels without the time commitment of IV sessions Comfortable with self-administration (or willing to learn) Frequent travelers or unpredictable schedules Already doing peptide therapy or GLP-1 injections NAD+ Nasal Spray The Convenience Play NAD+ delivered via nasal mucosa using a metered-dose spray